Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuefu Zhuyu oral liquid for stable angina in coronary heart disease
ChiCTR1900026899Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
- Start
- Nov 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of xuefu zhuyu in coronary arteriosclerosis and stable angina (3 arms), sponsored by First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine. Primary endpoint: Change from baseline in angina pain intensity on visual analogue scale at 12 weeks. Started Nov 2019; status: recruiting.
02
Drugs
xuefu zhuyu
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on ChiCTR1900026899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026899.